Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024;11(3):684-692.
doi: 10.14283/jpad.2024.35.

24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial

Affiliations
Randomized Controlled Trial

24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial

I J Sible et al. J Prev Alzheimers Dis. 2024.

Abstract

Background: Blood pressure variability is an emerging risk factor for dementia, independent and oftentimes beyond mean blood pressure levels. Recent evidence from interventional cohorts with rigorously controlled mean blood pressure levels suggest blood pressure variability over months to years remains a risk for dementia, but no prior studies have investigated relationships with blood pressure variability over shorter time periods.

Objectives: To investigate the potential effect of ambulatory blood pressure variability on the rate of cognitive outcomes under intensive vs standard blood pressure lowering.

Design: Post hoc analysis of the randomized, controlled, open-label Systolic Blood Pressure Intervention Trial clinical trial.

Setting: Multisite Systolic Blood Pressure Intervention Trial.

Participants: 793 participants at increased risk for cardiovascular disease and without history of dementia at study randomization.

Intervention: Standard (<140 mmHg systolic blood pressure target) vs intensive (<120 mmHg systolic blood pressure target) lowering of mean blood pressure.

Measurements: 24-hour ambulatory blood pressure monitoring 27 months after treatment randomization (standard vs intensive) and follow-up cognitive testing. Intraindividual blood pressure variability was calculated as the average real variability over 24-hour, daytime, and nighttime periods. Participants were categorized into 3 adjudicated clinical outcomes: no cognitive impairment, mild cognitive impairment, probable dementia. Cox proportional hazards models examined the potential effect of ambulatory blood pressure variability on the rate of cognitive outcomes under intensive vs standard blood pressure lowering. Associations with mean blood pressure were also explored.

Results: Higher systolic 24-hour blood pressure variability was associated with increased risk for probable dementia in the standard group (adjusted hazard ratio [HR]: 2.56 [95% CI 1.16, 5.62], p = 0.019) but not in the intensive group (HR: 0.54 [95% CI 0.24, 1.23], p = 0.141). Similar findings were observed with daytime systolic blood pressure variability but not nighttime blood pressure variability. Mean blood pressure was not associated with cognitive outcomes.

Conclusions: Higher systolic 24-hour and daytime blood pressure variability via ambulatory monitoring is associated with risk for dementia under standard blood pressure treatment. Findings support prior evidence that blood pressure variability remains a risk for dementia despite strict control of mean blood pressure levels.

Keywords: Blood pressure variability; ambulatory blood pressure monitoring; antihypertensives; dementia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to disclose.

Figures

Figure 1
Figure 1
Higher 24-hour systolic BPV via ambulatory monitoring is associated with increased risk for probable dementia in the standard treatment group Kaplan-Meier curves showing event rates for probable dementia after stratification by treatment group.

References

    1. de Heus RAA, Tzourio C, Lee EJL, et al. Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis. Hypertension. 2021;78(5):1478–1489. - PMC - PubMed
    1. Lattanzi S, Vernieri F, Silvestrini M. Blood pressure variability and neurocognitive functioning. J Clin Hypertens. 2018;20(4):645–647. - PMC - PubMed
    1. Rouch L, Cestac P, Sallerin B, et al. Visit-to-visit blood pressure variability is associated with cognitive decline and incident dementia: The S.AGES cohort. Hypertension. 2020;76:1280–1288. - PubMed
    1. de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen JAHR. Blood Pressure Variability and Progression of Clinical Alzheimer Disease. Hypertension. 2019;74(5):1172–1180. - PubMed
    1. Tully PJ, Yano Y, Launer LJ, et al. Association Between Blood Pressure Variability and Cerebral Small-Vessel Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2020;9(1):e013841. - PMC - PubMed

Publication types

Substances